Free Submission Public Relations & NewsPR-inside.com
 
DeutschEnglish

Get the latest news
with our RSS feed
rss feed
Add to My Yahoo!
More information
Business

Natus Medical to Hold 2009 Third Quarter Financial Results Conference Call on November 2


Print article Print article
Refer this article Refer to a friend
© Business Wire 2009
2009-10-27 20:36:01 -

Natus Medical Incorporated (Nasdaq:BABY) today announced that the Company intends to release its 2009 third quarter financial results before the market opens on Monday, November 2, 2009. Natus management will host an investment-community conference call the same day beginning at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time) to discuss those results and to answer questions.

Individuals interested in listening to

the conference call may do so by dialing (866) 700-7441 for domestic callers, or (617) 213-8839 for international callers, and entering reservation code 13698654. A telephone replay will be available for 48 hours following the conclusion of the call by dialing (888) 286-8010 for domestic callers, or 617-801-6888 for international callers, and entering reservation code 65677711.

The conference call also will be available real-time via the Internet at investor.natus.com : , and a recording of the call will be available on the Company's Web site for 90 days following the completion of the call.


About Natus Medical Incorporated

Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories.

Additional information about Natus Medical can be found at www.natus.com : .



Natus Medical IncorporatedBrienne H. Fisher, 650-802-0400Director
of Investor Relations InvestorRelations@Natus.com : mailto:InvestorRelations@Natus.com


Disclaimer: (c) 2010 Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Terms & Conditions | Privacy | About us | Contact PR-inside.com